FDA Advisory Committee Reform: Does Listening Session Suggest No Major Near-Term Changes?
Executive Summary
FDA seeks feedback at 13 June virtual hearing on three general topics related to advisory committees: panel composition, barriers to service for Special Government Employees, and public perception and understanding of the process.